Status:
RECRUITING
Brain Diseases on 7.0T Magnetic Resonance Imaging
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Brain Tumor
MRI
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This clinical trial studies the use of 7-Tesla (7T)and 3T magnetic resonance imaging (MRI) in detecting brain diseases. 7T MRI has increased detection sensitivity, including more accurate lesion delin...
Detailed Description
7T MRI increased detection sensitivity, attain superior anatomic resolution, higher spatial and spectral specificity of advanced quantitative techniques, and shorter scan times than 3T MRI. When appli...
Eligibility Criteria
Inclusion
- Age≥18 and ≤80
- Having brain diseases (eg: brain tumor, cerebrovascular diseases)
- Having no contraindications against MRI or intravenous contrast agent administration
- Clinically stable
Exclusion
- Age\<18 or \>80
- Pregnancy and other contraindication to MRI scan
- Informed consent not obtained
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05287750
Start Date
January 1 2022
End Date
September 1 2026
Last Update
March 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, China, 100853